The abstract is read at the publisher; the summary is JClub's.
Activation of PSAM 4 -GlyR with varenicline in NaV1.8-Cre mice reduces chronic pelvic pain and bladder overactivity in cyclophosphamide- and LPS-induced IC/BPS models.
- Why it matters: Bladder afferent sensitization is linked to chronic pain in interstitial cystitis/bladder painful syndrome, but translational chemogenetic tools for peripheral silencing are limited.
- What they did: AAV-Retro-CMV-DIO-PSAM 4 -GlyR-mCherry was injected into the bladder of NaV1.8-Cre mice to target bladder nociceptive afferents, then varenicline activation was tested in CYP- and LPS-induced IC/BPS models.
- The result: PSAM 4 -GlyR activation significantly alleviated pain and OAB without affecting voiding pressure, with effects comparable to Gi-DREADD and linked to reduced CGRP release and neurogenic inflammation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.